Recently, ZNF281 was shown to activate epithelial to mesenchymal transition (EMT) transcription factors, ZEB1 and SNAI1 via activation of the TGF-β pathway, promoting EMT and metastasis in breast cancer [70]. This evidence concerns the gene ZNF281 and breast carcinoma.